Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Liu, Jing ^a   Du, Jianfeng ^a   Zhang, Chi ^a   Walker, Jeffery W ^b   Huang, Xupei ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Damaged relaxation; Doppler analysis; Echocardiography

Indexed keywords

TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIASTOLIC HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE RELAXATION; HEART OUTPUT; HEART RATE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WILD TYPE;

ANIMALS; CARDIAC OUTPUT; CARDIAC OUTPUT, LOW; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; GENOTYPE; HEART ATRIA; HEART VENTRICLES; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; PHENOTYPE; TIME FACTORS; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34547921276     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01379.2006     Document Type: Article

References (42)

1. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 83: 580-593, 1998.
2. Chapelle JP. Cardiac troponin I troponin T: recent players in the field of myocardial markers. Clin Chem Lab Med 37: 11-20, 1999.
3. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 13: 227-239, 2003.
4. Du J, Zhang C, Liu J, Sidky C, Huang XP. A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice. Arch Biochem Biophys 456: 143-150, 2006.
5. Feigenbaum H, Armstrong WF, Ryan T. Evaluation of systolic and diastolic function of the left ventricle. In: Feigenbaum's Echocardiography (6th ed), Philadelphia, PA: Lippincott Williams & Wilkins, 2005, p. 138-180.
6. Giannuzzi P, Imparato A, Temporelli PL, de Vito F, Silva PL, Scapellato F, Giordano A. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cariol 23: 1630-1637, 1994.
7. Guo WD, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80: 393-399, 1997.
8. Huang XP, Du J. Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy. Acta Pharmacol Sin 25: 1569-1575, 2004.
9. Huang XP, Lee KJ, Riedel B, Zhang C, Lemanski LF, Walker JW. Thyroid hormone regulates slow skeletal troponin I gene inactivation in cardiac troponin I null mouse hearts. J Mol Cell Cardiol 32: 2221-2228, 2000.
10. Huang XP, Pi YQ, Lee KJ, Henkel AS, Gregg RG, Powers PA, Walker JW. Cardiac troponin I gene knockout, a mouse model of myocardial troponin I deficiency. Circ Res 84: 1-8, 1999.
11. James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 805-811, 2000.
12. Jia Y, Akerman S, Huang XP. Myofibril MgATPase activities and energy metabolism in cardiomyopathic mice with diastolic dysfunction. J Biomed Sci 11: 450-456, 2004.
13. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 88: 1059-1065, 2001.
14. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutation in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379-382, 1997.
15. Kogler H, Soergel DG, Murphy AM, Marban E. Maintained contractile reserve in a transgenic mouse model of myocardium stunning. Am J Physiol Heart Circ Physiol 280: H2623-H2630, 2001.
16. Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N, Ito H, Mabuchi H. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102: 663-669, 2000.
17. Mandinov L, Eberli FR, Seiler C, Hess OM. Diastolic heart failure. Cardiovasc Res 45: 813-825, 2000.
18. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33: 655-670, 2001.
19. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96: 2953-2958, 1997.
20. Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutation. J Clin Invest 111: 209-216, 2003.
21. Murphy AM. Troponin I, in sickness and in health and normal development. Circ Res 91: 449-450, 2002.
22. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15: 167-184, 2002.
23. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 44: 20-36, 1999.
24. Ricchiuti V, Zhang J, Apple FS. Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling. Clin Chem 43: 990-995, 1997.
25. Rivenes SM, Kerrney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 102: 876-882, 2000.
26. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
27. Sanbe A, James J, Tuzcu V, Nas S, Martin L, Gulick J, Osinska H, Sakthivel S, Klevitsky R, Ginsburg KS, Bers DM, Zinman B, Lakatta EG, Robbins J. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation 111: 2330-2338, 2005.
28. Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X, Hewett TE, Klevitsky R, Hayes E, Warshaw DM, Robbins J. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 296-302, 2000.
29. Seidman JG, Seidman C. The genetic basis for cardiomyopathy from mutation identification to mechanistic paradigm. Cell 104: 557-567, 2001.
30. Solaro RJ. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res 84: 122-124, 1999.
31. Sonel A, Sasseen BM, Fineberg N, Bang N, Wilensky RL. Prospective study correlating fibrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation 102: 1107-1113, 2000.
32. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, Turnbull DH. Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation 98: 912-918, 1998.
33. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 58: 447-481, 1996.
34. Toyo-Oka T, Ross J. Ca sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion. Am J Physiol Heart Circ Physiol 240: H704-H708, 1981.
35. Urboniene D, Dias FAL, Pena JR, Walker LA, Solaro RJ, Wolska BM. Expression of slow skeletal troponin I in adult mouse heart helps to maintain the left ventricular systolic function during respiratory hypercapnia. Circ Res 97: 70-77, 2005.
36. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57: 37-47, 2003.
37. Welsh TM, Kukes GD, Sandweiss LM. Differences of creatine kinase MB and cardiac troponin I concentrations in normal and diseased human myocardium. Ann Clin Lab Sci 32: 44-49, 2002.
38. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM. Myofibrillar carcium sensitivity of isometric tension is increased in human dilated cardiomyopathies. J Clin Invest 98: 167-176, 1996.
39. Westfall MV, Solaro RJ. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res 70: 302-313, 1992.
40. 2+ affinity of cardiac troponin C. J Biol Chem 270: 30773-30780, 1995.
41. Zhou YQ, Foster FS, Parkes R, Adamson SL. Developmental changes in left and right ventricular diastolic filling patterns in mice. Am J Physiol Heart Circ Physiol 285: H1563-H1575, 2003.
42. Zhou YQ, Zhu Y, Bishop J, Davidson L, Henkelman RM, Bruneau BG, Foster FS. Abnormal cardiac inflow patterns during postnatal development in a mouse model of Holt-Oran syndrome. Am J Physiol Heart Circ Physiol 289: H992-H1001, 2005.